1394PA multicenter study of mutational profiling of Chinese ALK+ non-small cell lung cancer patients with acquired resistance to crizotinib using next generation sequencing. (23rd October 2018) - Xu, C; Wang, W; Zhuang, W; Song, Z; Zhu, Y; Chen, G; Fang, M; Lv, T; Song, Y